Why Attend?


  • Discover new reimbursement models which are impacting market access
  • Stay abreast of important Market Access trends and updates from across the globe
  • Hear from leading international HTA agencies
  • Learn from case studies on demonstrating product value
  • Understand the payers’ perspective
  • Discuss how to generate, apply and present ‘real world’ evidence to maximise patient access
  • Analyse and compare pricing and partnering models
  • Gain best practice insights for market access of high value and orphan drugs in the multi speaker focus day
  • Leverage evidence planning and payer strategy for optimum pricing, market access and launch
  • Network with pioneers, influencers and innovators and return to your company with new ideas and relationships

Who Attends?



“It was very good networking experience and interesting to see people like Thomas Mueller and NICE officials participate in the discussions with industry.”

Patient Services Manager, Shire Pharmaceuticals